Latest posts
-
PRISM MediaWire – Weekly Press Resume – Nov. 6 to Nov. 10, 2023
New York, New York, Nov. 10, 2023 PRISM MediaWire – Weekly Press Resume Nov. 6 to Nov. 10, 2023 Two Hands Corporation Launches Sports Illustrated Line Protein Bars in Canada BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023 Evergreen Group unveils new corporate haven in M’sia with HWG partnership
-
Oncocyte Reports Third Quarter 2023 Financial Results
-Launching First Products in 1H 2024- -Conference Call on Thursday, November 9, 2023, at 5:00 a.m. PT / 8:00 a.m. ET- IRVINE, CA, November 09, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today reported financial results for the third quarter of 2023, ended September 30, 2023. Third Quarter and Recent Highlights Josh Riggs, CEO
-
PRISM MarketView Insight: Is It Time to Invest in Small-Cap Stocks?
NEW YORK, NY, November 7, 2023 – As the Russell 2000 recently recorded its best week in over two years, investors are turning their attention to the potential end of the Federal Reserve’s interest rate hike cycle. This shift in sentiment has sparked a remarkable surge in previously downtrodden market segments, with the index climbing
-
Two Hands Corporation Launches Sports Illustrated Line Protein Bars in Canada
TORONTO, November 6, 2023 – Two Hands Corporation (CSE: TWOH) (OTC: TWOH), a leading innovator in the food industry, is thrilled to announce the introduction of the protein-bar product lines from Sports Illustrated Nutrition a Smart for Life company to the Canadian marketplace. The new line of protein bars is a clean and energizing, non-GMO,
-
Oncocyte to Announce Third Quarter 2023 Financial Results
Conference Call and Webcast on Thursday, November 9, 2023, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, November 3, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, announced today that the company will host a conference call and webcast on Thursday, November 9, 2023, at 5:00 a.m. Pacific Time / 8:00 a.m.
-
PRISM MediaWire – Weekly Press Resume – Oct. 30 to Nov. 3, 2023
New York, New York, Nov. 3, 2023 PRISM MediaWire – Weekly Press Resume Oct. 30 to Nov. 3, 2023 Metatron Pioneers Real-Time Stock Insights with AI-Enhanced Stock Trendz PRISM MarketView Highlights Its Spooktacular Zombie Index For Halloween Franklin Mining Bolivia (a branch of Franklin Mining, Inc.) and Rockin’ G Gold Form New Joint Venture for
-
PRISM Emerging Clean Energy Index Highlights: Uranium Companies Outshine as Solar Demand Dips in 2023
NEW YORK, NY, November 2, 2023 – The clean energy sector has experienced a tumultuous year, with the solar industry facing a potential downturn in installation demand. Yet, amid the turbulence, not all is grim within the realm of sustainable energy. A shining beacon of resilience has been the nuclear energy segment, largely propelled by
-
AmpliTech Group Announces New Product Lines; Adds E-Commerce Capabilities to Website
HAUPPAUGE, NY, November 2, 2023 – AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks and a worldwide distributor of packages and lids for integrated circuit assembly, and designer of complete 5G/6G systems, is proud to introduce its latest new product offerings, which include
-
PRISM MarketView Oil & Gas Index Update: WTI Crude Reverses Gains, Earnings Season in Full Swing
NEW YORK, NY, November 1, 2023 – PRISM MarketView, a leading provider of market insight and company news, today provides its PRISM Emerging Oil & Gas overview. US equities finished mostly higher in Wednesday afternoon trading, near best levels. The S&P 500 Energy Index closed down (0.33%) versus the S&P 500 which was up +1.05%,
-
PRISM MARKETVIEW’S EMERGING HEALTHCARE INDEX HIGHLIGHTS LIFEMD, INC. AS ITS LARGEST YTD GAINER, UP ~226%
NEW YORK, NY, November 1, 2023 – LifeMD, Inc. is the current YTD leader in the PRISM Emerging Healthcare Index. The company has seen a ~226% increase this year and is trading at approximately $6 per share. This price falls on the higher end of its 52-week range of $1.14 – $7.40 which may indicate the potential for